A detailed history of Keynote Financial Services LLC transactions in Amgen Inc stock. As of the latest transaction made, Keynote Financial Services LLC holds 4,658 shares of AMGN stock, worth $1.23 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares
4,658
Previous 4,898 4.9%
Holding current value
$1.23 Million
Previous $1.53 Billion 1.93%
% of portfolio
1.15%
Previous 1.28%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$309.38 - $337.38 $74,251 - $80,971
-240 Reduced 4.9%
4,658 $1.5 Billion
Q2 2024

Jul 24, 2024

BUY
$262.75 - $319.31 $7,882 - $9,579
30 Added 0.62%
4,898 $1.53 Billion
Q1 2024

Jun 13, 2024

BUY
$268.87 - $324.56 $1.31 Million - $1.58 Million
4,868 New
4,868 $1.38 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Keynote Financial Services LLC Portfolio

Follow Keynote Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keynote Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keynote Financial Services LLC with notifications on news.